Baxter signs British flu vaccine deal

Aug 17, 2007

Baxter International said it has entered into an agreement to supply Britain with flu vaccine in the event of a bird flu pandemic.

The Deerfield, Ill., company is in the final stages of testing for a vaccine against H5N1 strains of avian influenza.

Baxter said it will manufacture its pandemic vaccine in a serum-free, vero cell-based system that accelerates vaccine availability. The company said vaccines produced using this process can be released within approximately 12 weeks, significantly earlier than with traditional egg-based systems.

The vero cell culture gives the company the flexibility to quickly respond to emerging variant pandemic virus strains, Baxter said in a news release.

The Chicago Tribune said the advanced supply agreement could be worth tens of millions of dollars to the company over the next four years.

British health officials said they signed more than $300 million in contracts with Baxter and GlaxoSmithKline to supply a vaccine as soon as the strain is identified by the World Health Organization.

Copyright 2007 by United Press International

Explore further: EU regulator: Morning-after pill OK for all women

add to favorites email to friend print save as pdf

Related Stories

Expert panel to view confidential swine flu papers

May 19, 2010

(AP) -- An expert panel investigating the World Health Organization's response to last year's swine flu outbreak said Wednesday it wants to see confidential exchanges between the U.N. body and drug companies.

EU drug agency: License 2 swine flu vaccines

Sep 25, 2009

(AP) -- The European Union's drug regulator recommended Friday that two swine flu vaccines be licensed in the 27-nation bloc to ensure their availability before the start of the normal flu season.

Europe fast-tracking swine flu vaccine

Jul 26, 2009

(AP) -- In a drive to inoculate people against swine flu before winter, many European governments say they will fast-track the testing of a new flu vaccine, arousing concern among some experts about safety ...

Fight for swine flu vaccine could get ugly

Jul 16, 2009

(AP) -- An ugly scramble is brewing over the swine flu vaccine - and when it becomes available, Britain, the United States and other nations could find that the contracts they signed with pharmaceutical companies are easily ...

Recommended for you

EU regulator: Morning-after pill OK for all women

14 hours ago

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

19 hours ago

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

Zydelig approved for three types of blood cancer

19 hours ago

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Journal raises concern about blood-thinning drug

Jul 23, 2014

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

User comments : 0